ZA897414B - Pteridines - Google Patents

Pteridines

Info

Publication number
ZA897414B
ZA897414B ZA897414A ZA897414A ZA897414B ZA 897414 B ZA897414 B ZA 897414B ZA 897414 A ZA897414 A ZA 897414A ZA 897414 A ZA897414 A ZA 897414A ZA 897414 B ZA897414 B ZA 897414B
Authority
ZA
South Africa
Prior art keywords
group
pteridines
substituted
carbon atom
excepting
Prior art date
Application number
ZA897414A
Other languages
English (en)
Inventor
Armin Heckel
Heckel Armin
Joerg Lebsanft
Lebsanft Joerg
Uwe Bamberger
Bamberger Uwe
Avner Ramu
Ramu Avner
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of ZA897414B publication Critical patent/ZA897414B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
    • C07D475/08—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4 with a nitrogen atom directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA897414A 1988-10-01 1989-09-29 Pteridines ZA897414B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3833393A DE3833393A1 (de) 1988-10-01 1988-10-01 Verwendung von pteridinen zur verhinderung der primaeren und sekundaeren resistenz bei der chemotherapie und diese verbindungen enthaltende arzneimittel

Publications (1)

Publication Number Publication Date
ZA897414B true ZA897414B (en) 1991-06-26

Family

ID=6364156

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA897414A ZA897414B (en) 1988-10-01 1989-09-29 Pteridines

Country Status (19)

Country Link
EP (1) EP0362645B1 (no)
JP (1) JPH02256676A (no)
KR (1) KR910006289A (no)
AT (1) ATE106728T1 (no)
AU (1) AU620645B2 (no)
DD (1) DD299062A5 (no)
DE (2) DE3833393A1 (no)
DK (1) DK480489A (no)
ES (1) ES2056174T3 (no)
FI (1) FI92699C (no)
HU (1) HU205761B (no)
IL (1) IL91814A (no)
MX (1) MX9203034A (no)
NO (1) NO175979C (no)
NZ (1) NZ230833A (no)
PT (1) PT91836B (no)
SU (1) SU1720491A3 (no)
UA (1) UA8028A1 (no)
ZA (1) ZA897414B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7276506B2 (en) 1998-12-28 2007-10-02 4 Aza Bioscience Nv Immunosuppressive effects of pteridine derivatives
ES2229803T3 (es) * 1998-12-28 2005-04-16 4 Aza Bioscience Nv Efectos inmunosupresivos de derivados de pteridina.
DE10202468A1 (de) * 2002-01-23 2004-09-30 Faustus Forschungs Cie. Translational Cancer Research Gmbh Pteridinderivate, Verfahren zu deren Herstellung und ihre Verwendung
ATE369861T1 (de) * 2003-09-12 2007-09-15 4 Aza Ip Nv Pteridin-derivate zur behandlung von erkrankungen im zusammenhang mit tnf-alpha
ATE369862T1 (de) * 2003-10-17 2007-09-15 4 Aza Ip Nv Heterocyclus-substituierte pteridin-derivate und ihre verwendung in der therapie
RU2447074C2 (ru) * 2005-05-12 2012-04-10 Тиботек Фармасьютикалз Лтд. Птеридины, полезные в качестве ингибиторов hcv, и способы получения птеридинов
US10144736B2 (en) 2006-07-20 2018-12-04 Gilead Sciences, Inc. Substituted pteridines useful for the treatment and prevention of viral infections
PT3321265T (pt) 2015-03-04 2020-07-07 Gilead Sciences Inc Compostos 4,6-diamino-pirido[3,2-d]pirimidina compounds e a sua utilização como moduladores de receptores do tipo toll
KR20160003575A (ko) 2015-11-09 2016-01-11 정민시 발전기용 동력전달장치
ES2826748T3 (es) 2016-09-02 2021-05-19 Gilead Sciences Inc Derivados de 4,6-diamino-pirido[3,2-d]pirimidina como moduladores de receptores de tipo Toll
JP6746776B2 (ja) 2016-09-02 2020-08-26 ギリアード サイエンシーズ， インコーポレイテッド Ｔｏｌｌ様受容体調節剤化合物
TW202212339A (zh) 2019-04-17 2022-04-01 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
TWI751516B (zh) 2019-04-17 2022-01-01 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
TW202115056A (zh) 2019-06-28 2021-04-16 美商基利科學股份有限公司 類鐸受體調節劑化合物的製備方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3574206A (en) * 1965-04-15 1971-04-06 Boehringer Sohn Ingelheim 2,7-dimorpholino-4-amino-6-phenyl-pteridines
NL129630C (no) * 1966-10-14
DE1617336C2 (de) * 1966-11-25 1982-07-01 C.H. Boehringer Sohn, 6507 Ingelheim Arzneimittel gegen Angina pectoris
DE1795515A1 (de) * 1967-08-18 1972-03-30 Thomae Gmbh Dr K Verfahren zur Herstellung von neuen Pteridinen
DE1795516A1 (de) * 1967-12-15 1972-01-27 Thomae Gmbh Dr K 4-AEthanolisopropanolamino-2-(2'-methylmorpholino)-7-morpholino-6-phenyl-pteridin
DE1921308A1 (de) * 1969-04-25 1971-01-07 Boehringer Sohn Ingelheim Herzwirksame Zubereitungen
US4767761A (en) * 1987-11-04 1988-08-30 Dana-Farber Cancer Institute, Inc. Ornithine derivatives and their use as methotrexate-resistant cell inhibitors

Also Published As

Publication number Publication date
FI894615A0 (fi) 1989-09-29
DK480489A (da) 1990-04-02
IL91814A0 (en) 1990-06-10
KR910006289A (ko) 1991-04-29
UA8028A1 (uk) 1995-12-26
DE58907824D1 (de) 1994-07-14
AU620645B2 (en) 1992-02-20
PT91836A (pt) 1990-04-30
NO175979B (no) 1994-10-03
DE3833393A1 (de) 1990-04-05
NO175979C (no) 1995-01-11
FI92699C (fi) 1994-12-27
HU205761B (en) 1992-06-29
NZ230833A (en) 1991-05-28
SU1720491A3 (ru) 1992-03-15
DD299062A5 (de) 1992-03-26
IL91814A (en) 1994-02-27
EP0362645A3 (de) 1992-03-25
ATE106728T1 (de) 1994-06-15
NO893879L (no) 1990-04-02
PT91836B (pt) 1995-07-18
FI894615A (fi) 1990-04-02
HUT52504A (en) 1990-07-28
MX9203034A (es) 1992-07-01
FI92699B (fi) 1994-09-15
EP0362645B1 (de) 1994-06-08
DK480489D0 (da) 1989-09-29
ES2056174T3 (es) 1994-10-01
JPH02256676A (ja) 1990-10-17
EP0362645A2 (de) 1990-04-11
AU4174989A (en) 1990-04-05
NO893879D0 (no) 1989-09-29

Similar Documents

Publication Publication Date Title
ZA897414B (en) Pteridines
ES8405782A1 (es) Un procedimiento para la produccion de un derivado de carbostirilo.
HRP940524B1 (en) Therapeutic heterocyclic compounds
ES8707238A1 (es) Procedimiento para preparar pteridinas
GB1135893A (en) Imidazo (1,2-b) pyridazine derivatives
ES462700A1 (es) Procedimiento para la preparacion de nuevas 1h-pirazolo(3,4-b)piridinas.
ES390924A1 (es) Procedimiento para la preparacion de derivados del acido nicotinico.
ES8701156A1 (es) Un procedimiento para producir un derivado de 2-(3,5-dial- quil-4-hidroxifenil)indol
GB1084150A (no)
EP0233291A4 (en) 2-ARYLBENZOTHIAZINE DERIVATIVES.
SE314986B (no)
ES345993A1 (es) Procedimiento para la obtencion de nuevas pteridinas.
ES462746A1 (es) Procedimiento para la preparacion de nuevas piridobenzodia- zepinas.
ES345992A1 (es) Procedimiento para la obtencion de nuevas pteridinas.
ES394967A1 (es) Procedimiento para la preparacion de 3-alcohil-5-ariloxime-tilisoxazoles.
DE3564106D1 (en) 4-phenylaminopyridine derivatives, process of the preparation thereof and pharmaceutical compositions containing them
GB1320548A (en) Nitrofurylaminoalkoxy-pyrimidines
HU9302260D0 (en) Tetrahydro-naphtaline derivatives and methods for producing these compounds and for preparing pharmaceutical preparatives containing them
ES304710A1 (es) Procedimiento para la preparaciën de 1,3,5-triacinas
GB1341170A (en) Alkyl sulphonic acid esters of 1,3,2-oxazaphospha-cyclic compounds
ES485333A1 (es) Procedimiento para preparar derivados 5,6,7,8-tetrahidro-4 (3h)-quinazolinonicos y sus sales
GB1085922A (en) Improvements in and relating to therapeutic compositions containing 2-amino-oxazolin-4-one derivatives, novel derivatives of this type and process for preparing same
ES398968A1 (es) Procedimiento para la obtencion de derivados de la 1,2,4 pirimido (4,5-e) tiadicina.